Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8259154 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2016 | 8 Pages |
Abstract
Altogether, increasing carnitine availability affects acylcarnitine profiles in plasma and liver but does not modulate glucose tolerance or insulin sensitivity. This may be due to the lack of an effect on muscle acylcarnitine profiles, as muscle tissue is an important contributor to whole body insulin sensitivity. These results warrant caution on making associations between plasma acylcarnitine levels and insulin resistance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Marieke G. Schooneman, Riekelt H. Houtkooper, Carla E.M. Hollak, Ronald J.A. Wanders, Frédéric M. Vaz, Maarten R. Soeters, Sander M. Houten,